z-logo
Premium
HLA Sharing, Anti‐Paternal Cytotoxic Antibodies and MLR Blocking Factors in Women with Recurrent Spontaneous Abortion
Author(s) -
Kishore Raj,
Agarwal Suraksha,
Halder A.,
Das V.,
Shukla B. R. K.,
Agarwal S. S.
Publication year - 1996
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/j.1447-0756.1996.tb00962.x
Subject(s) - medicine , cytotoxic t cell , abortion , blocking antibody , immunology , mixed lymphocyte reaction , antibody , human leukocyte antigen , immune system , pregnancy , t cell , antigen , genetics , biology , in vitro
Objective : To study the prevalence of HLA sharing between spouses and its correlation with presence of antipaternal cytotoxic antibody (APCA) and mixed lymphocyte reaction (MLR) blocking factors in recurrent spontaneous aborters (RSA). Design : Study was carried out at Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI), Lucknow, from 1988–1992. Hundred coupes with 3 or more consecutive recurrent spontaneous abortions and equal number of age, parity and ethinically matched normal controls were selected for studying HLA, APCA and MLR blocking factors. Meta‐analysis was performed using standard formula and significance was tested by Chi‐square analysis. Results : Significant HLA sharing was observed in couples with RSA at A and DR loci compared to normal controls (p < 0.001). Twenty‐seven point eight percent of couples with RSA were positive for APCA compared to 49% of controls (p < 0.01). MLR blocking factors were detected in 26% couples with RSA compared to 78% in controls (p < 0.001). An inverse correlation between HLA sharing and APCA and MLR positivity was demonstrated. Conclusion : The study supports that greater HLA sharing between spouses, associated with lack of an appropriate immune response to them could be responsible for RSA.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here